PredxBioThe Spatial Medicine Company™
[email protected] ↗
Experience SpaceIQ® Live at SITC 2026. Spatial Medicine in Action. Booth 713, Phoenix. Quantitative QC, Tissue States, Interpretable Models, and Clinical Compression support biomarker strategy, patient stratification, trial enrichment, and response/resistance, with histology and multiplex tissue imagery at the left.

SITC 2026 · PHOENIX · BOOTH 713

See Spatial Medicine
in action

Experience SpaceIQ® with the scientists building it. Bring your oncology question and explore how tissue quality, spatial biology, and explainable AI can inform your next development decision.

Request a meeting →
Save our Tech Talk
GoogleOutlookApple

EXPERIENCE SPACEIQ®

From tissue measurements to decisions

Quantitative QC

Identify image and biological artifacts before they shape downstream analysis.

Tissue States

Reveal patterns of cellular organization and the biology of local tissue environments.

Interpretable Models

Connect spatial patterns with mechanisms, response, and resistance.

Clinical Compression

Translate rich spatial discoveries into focused biomarker candidates for validation.

PREDXBIO AT SITC

Join the conversation

TECH TALK · FRIDAY, NOVEMBER 6

Beyond Cell Counts: Translating Spatial Biology into Spatial Medicine with SpaceIQ®

How can we translate the complexity of spatial tissue biology into insights that inform therapeutic development and clinical care?

Join PredxBio for a 15-minute Tech Talk introducing SpaceIQ®, our platform for advancing spatial biology toward spatial medicine.

Through immuno-oncology examples, we'll explore how quantitative spatial quality control, biologically grounded tissue states, and interpretable decision models reveal patterns of therapeutic response and resistance.

We'll also show how these discoveries can be translated into predictive biomarkers, patient stratification strategies, and practical clinical assays, bridging biological discovery, therapeutic development, and precision medicine.

Friday, November 6, 2026 | 5:45–6:00 PM MST
Location: Phoenix Convention Center, Exhibit Hall Presentation Stage

Presented by PredxBio | The Spatial Medicine Company™

View the official SITC event →

Add the Tech Talk to your calendar

GoogleOutlookApple

LATE-BREAKING POSTER #1190 · SATURDAY, NOVEMBER 7

Spatial and phenotypic characterization of tertiary lymphoid structures and immune organization in cutaneous squamous cell carcinoma using multiplex immunofluorescence

Presented by Filippo Pullara, PhD, with colleagues from PredxBio, UPMC Hillman Cancer Center, and NYU Langone Health.

See the official SITC program for poster presentation times.

Beyond Cell Counts: Translating Spatial Biology into Spatial Medicine with SpaceIQ®, content and views expressed therein are those of PredxBio and not of SITC.

LET’S MEET

Bring us your oncology question

Tell us what you would like to explore and when you are available. Our team will reply to confirm a meeting at Booth 713.

All meeting times are in Phoenix local time (MST). Please share only non-confidential project information.

Subscribe to our Newsletter

* indicates required





Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

Linkedin-in

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Linkedin-in

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Linkedin-in

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.